TheÂ completeÂ 2011Â presentations of speakers at MANIFESTING THE MIND in Madison Wisconsin are now available on-line. Please follow the link and enjoy an incredible array of speakersÂ discussingconsciousnessÂ and the neurology involved in the process.
Heffter scientists will be speaking at this conference, in Madison, WI on April 28-29, 2011:
OVERVIEW: The over-arching theme of this Forum’s is exploration of the Mind-Brain phenomenon and how this relates to human consciousness. The challenge faced by planners of Manifesting the Mind was to respect the many interests of our audience, to cover a wide range of topics — ethnobotany to neurotransmitters to recent clinical reports on the use of entheogens. One goal of the Forum is the exploration of these diverse topics in understanding human potential and how we conceptualize the next step in the evolution of consciousness on this planet.
The Archives of General Psychiatry has just published the report of Dr. Charles Grob’s experimental treatment of anxiety in cancer patients. You can view the abstract here:
Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. (2011) Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer. Arch Gen Psychiatry. 2011 Jan;68(1):71-8.
The online publication in September, 2010 generated quite a bit of media attention, and here are links to some of the stories:
Daily Breeze:Â http://www.dailybreeze.com/news/ci_16007975?source=email
CBS Los Angeles video:Â http://www.youtube.com/watch?v=PrXX6lAdUbQ
Screening will be in Namaste Hall, 1453 Mission Street, 3rd floor, San Francisco, CA. Included in the film is an interview with Annie Levy about her experience taking psilocybin as a cancer patient in Dr. Charles Grob’s research study.
7:00 pm Welcome by Joseph Subbiondo
7:15 to 8:30 pm Film screening
8:30 to 9:15 pm Panel discussion with Robert Barnhart, Roslyn Dauber, Frank Echenhofer, and Charles Grob.
On February 24, 2010, Scienceline published this story about Pam Sakuda, the first person in decades to talk about the experience of psychedelic treatment in a research study.
The Spring, 2010 issue of NYU Physician published the history of the Heffter-supported study at NYU and a subject’s recounting of how he “experienced a sense of transformation in his ability to feel supported and lovedâ€ with psilocybin treatment.
Afterwords, he said, “This has helped me resolve past issues about my parents and siblings. Now, I can die unburdened by the angst of my childhood.â€
In April, 2010, both ABC News and the Associated Press published reports about cancer patient Nicky Edlich’s story of her “revelatory” psilocybin treatment at the Heffter-supported project at New York University, led by Dr. Stephen Ross, MD.
At TEDx MidAtlantic in November 2009, Dr. Roland Griffiths, a member of Heffter Research Instituteâ€™s Board of Directors, showcased the results of his astonishing study: â€œPsilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.â€
On April 11, 2010, The New York Times published this article about Dr. Clark Martin, a retired clinical psychologist from Vancouver, WA, whose cancer-related depression was relieved during Heffter-supported research.
Heffter Board member, Dr. Roland Griffiths, leads this Johns Hopkins-based study concerning the effects of psilocybin on the psychological distress of patients who have been diagnosed with potentially life-threatening cancer.
photo credit: Alan S. Weiner